로딩 중…
지수 로딩 중…
Enliven Therapeutics, Inc.
ELVN· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$45.10+0.53%
2026-06-18
Price Chart
Enliven Therapeutics, Inc.+109.09%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $2.75B |
| Revenue | $0.00 |
| Net Income | $-99M |
| Total Assets | $465M |
| Net Assets | $453M |
| Value | |
| P/B | 6.06x |
| FCF Yield | -2.39% |
| Profitability | |
| ROE | -21.79% |
| ROA | -21.25% |
| Financial Health | |
| Debt Ratio | 2.53% |
| Total Debt | $302000.00 |
| FCF | $-66M |
| Cash | $132M |
| Current Ratio | 40.32x |
| Performance | |
| 1Y Return | 109.09% |
| 1M Return | 12.27% |
| From 52W High | -7.07% |
| 1Y MDD | -36.84% |
| Trading | |
| Volume | 2,159,450 shares |
| Trading Value | $97M |
| Per Share | |
| EPS | $-1.83 |
| BPS | $8.11 |